Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Lung Cancer Patients

Histone deacetylase inhibitor (HDACi, vorinostat) responses were studied in murine and human lung cancer cell lines and genetically-engineered mouse lung cancer models. Findings were compared with a window of opportunity trial in aerodigestive tract cancers. In human (HOP62, H522 and H23) and murine...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ma, Tian, Galimberti, Fabrizio, Erkmen, Cherie P., Memoli, Vincent, Chinyengetere, Fadzai, Sempere, Lorenzo, Beumer, Jan H., Anyang, Bean N., Nugent, William, Johnstone, David, Tsongalis, Gregory J., Kurie, Jonathan M., Li, Hua, DiRenzo, James, Guo, Yongli, Freemantle, Sarah J., Dragnev, Konstantin H., Dmitrovsky, Ethan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742691/
https://ncbi.nlm.nih.gov/pubmed/23686769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0933
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak